[1]
N. Budiarti, Z. Ikawati, A. Nurrochmad, and T. A. Arief, “Understanding the Safety Profile of Imatinib in Asian Chronic Myeloid Leukemia Patients: A Systematic Review”, JINTO, vol. 12, no. 1, pp. 2–14, Mar. 2026.